Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sarker

Showing results (241-250 of 245) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 245 results.
Nutrients|June 2, 2021
Bee Pollen: Current Status and Therapeutic PotentialShaden A M Khalifa, Mohamed H Elashal, Nermeen Yosri, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 7, 2017
Modulation of Antimalarial Activity at a Putative Bisquinoline Receptor In Vivo Using Fluorinated BisquinolinesAlistair J Fielding, Valentina Lukinović, Philip G Evans, et al.
Current Pharmaceutical Design|July 26, 2017
Anthocyanins: Multi-Target Agents for Prevention and Therapy of Chronic DiseasesSwathi Putta, Nagendra S Yarla, Ilaria Peluso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2018
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinomaG K Abou-Alfa, S Qin, B-Y Ryoo, et al.
Nature Communications|July 13, 2026
Nrf2-mediated metabolic reprogramming drives regulatory T cell accumulation in hepatocellular carcinomaE Perpiñán, N Sompairac, D Marin Correa, et al.
Pageof 25

Showing results (241-250 of 245) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 245 results.
Nutrients|June 2, 2021
Bee Pollen: Current Status and Therapeutic PotentialShaden A M Khalifa, Mohamed H Elashal, Nermeen Yosri, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 7, 2017
Modulation of Antimalarial Activity at a Putative Bisquinoline Receptor In Vivo Using Fluorinated BisquinolinesAlistair J Fielding, Valentina Lukinović, Philip G Evans, et al.
Current Pharmaceutical Design|July 26, 2017
Anthocyanins: Multi-Target Agents for Prevention and Therapy of Chronic DiseasesSwathi Putta, Nagendra S Yarla, Ilaria Peluso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2018
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinomaG K Abou-Alfa, S Qin, B-Y Ryoo, et al.
Nature Communications|July 13, 2026
Nrf2-mediated metabolic reprogramming drives regulatory T cell accumulation in hepatocellular carcinomaE Perpiñán, N Sompairac, D Marin Correa, et al.
Pageof 25